A new machine learning model built using a simple and interpretable approach predicts in-hospital death in patients with acute liver failure and reveals top risk drivers.
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
Machine learning predicts who will decline faster in Alzheimer’s disease using routine clinic data
Researchers developed and validated ElasticNet machine learning models that predict 12-month MMSE and BADL outcomes in ...
Both approaches identified hemoglobin as one of the most significant predictors of CKD risk. Additional top-ranked features included blood urea, sodium levels, red blood cell count, potassium, and ...
Yale researchers have developed a machine learning model, called Immunostruct, that can help scientists create more ...
Immunis, Inc., a clinical-stage biotech company targeting age-related diseases, today announced it has entered an exclusive licensing agreement with Toray to develop and commercialize a drug candidate ...
More than half of transplant recipients in a large analysis developed chronic graft-versus-host disease, and 15% died from causes other than cancer relapse. Those numbers capture the uneasy truth of ...
Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...
Approximately one in seven adults in the United States has kidney disease, where the organs responsible for filtering waste ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results